Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

ECB. 2022; 11(10): 95-101


EVALUATION OF SUB-ACUTE TOXICITY OF THE ETHANOLIC ROOT EXTRACT OF COLEUS VETTIVEROIDES IN ALBINO WISTAR RATS.

Kadmad Abdul Hameed Mohamed Azar, Devaraj Ezhilarasan, Dr. Suresh Rao, Kamatham Praveen.




Abstract

Background: In this study, we evaluated the oral sub-acute toxicity study of ethanolic roots extract of Coleus
vettiveroides on animal models. Methods:The sub-acute oral toxicity study was carried out as per OECD 423 guidelines. The
study was approved by the Institutional Animal Ethics Committee (IAEC). In sub-acute toxicity study, the oral dose (250, 500
and 1000 mg/kg) of coleus vettiveroides root extract was administered for 28 days to the three animals groups and their body
weight, hematological, serum hepatic biochemical parameters were evaluated and compared to normal group by sacrificing all
group animals. Results: Coleus vettiveroidestreated groups revealed neither mortality nor any significant changes were observed.
The result indicates that the oral administration of ethanolic root extract of Coleus vettiveroides plant did not produce any
significant toxic effect in albino wistar rats. Conclusions: The extract can be utilized safely for therapeutic use in pharmaceutical
formulations.

Key words: Sub acute toxicity, Coleus vettiveroides, hematology, liver.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.